The Effect of Dietary Nitrate on the Oral Microbiome (Microbio)
The Effect of Dietary Nitrate on the Oral Microbiota, Markers of Nitric Oxide Bioavailability and Cardiovascular Health in in Young and Older Adults
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Devon
-
Exeter, Devon, United Kingdom
- Diabetes & Vascular Medicine Research Centre, Clinical Research Facility
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy young (18-30 yr) and older adults (65-80 yr)
- Male and female
- Willing to undergo the experiments as detailed in the informed consent documentation
- Willing and capable of providing written, informed consent.
Exclusion Criteria:
- Individuals receiving medication for pulmonary, cardiovascular, or metabolic conditions, ulcerative colitis or renal disease
- Having an active oral disease or dentures
- Having resting BP >140/90 mmHg
- Having used antibiotics within 3 months
- Lacking willingness or capacity to give informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: QUADRUPLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Nitrate-rich beetroot juice
2 x 70mL concentrated juice per day for 14 days
|
concentrated beetroot juice
|
|
PLACEBO_COMPARATOR: Nitrate-depleted beetroot juice
2 x 70mL concentrated juice per day for 14 days
|
concentrated beetroot juice
|
|
OTHER: Antibacterial mouthwash
2 x 10mL antibacterial mouthwash per day for 14 days
|
2 x 10 mL antibacterial mouthwash per day for 14 days
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantity of nitrate -reducing bacteria
Time Frame: 14 days
|
Change in total quantity of nitrate-reducing bacteria as measured by sequencing bacterial 16S rRNA genes
|
14 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nitric oxide bioavailability - plasma nitrite
Time Frame: 14 days
|
Change in nitrite concentration of plasma as measured by ozone-based chemiluminescence
|
14 days
|
|
Nitric oxide bioavailability - salivary nitrite
Time Frame: 14 days
|
Change in nitrite concentration of saliva as measured by ozone-based chemiluminescence
|
14 days
|
|
Nitric oxide bioavailability - plasma nitrate
Time Frame: 14 days
|
Change in nitrate concentration of plasma as measured by ozone-based chemiluminescence
|
14 days
|
|
Nitric oxide bioavailability - salivary nitrate
Time Frame: 14 days
|
Change in nitrate concentration of saliva as measured by ozone-based chemiluminescence
|
14 days
|
|
Blood pressure
Time Frame: 14 days
|
Change in systolic and diastolic BP
|
14 days
|
|
Flow mediated dilation
Time Frame: 14 days
|
Change in flow mediated dilation
|
14 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Andrew M Jones, PhD, University of Exeter
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 1718/14
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.